Subject: RXMD Purchases Building for New Corporate Headquarters and Third Pharmacy Location Cementing 2018 Expansion

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
RXMD Purchases Building for New Corporate Headquarters and Third Pharmacy Location Cementing 2018 Expansion
Hot Stock to WatchHot Stock to Watch

Company: Progressive Care Inc. (OTCQB: RXMD)


Price: 0.06

Change (%): - 0.0035 (5.51)

Volume: 327,852
RXMD Chart

Progressive Care Enters into Definitive Agreements to Purchase Property for Third Pharmacy Location in South Florida

MIAMI, Oct. 30, 2018 (GLOBE NEWSWIRE) - Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, today announced that through its subsidiary Pharmco, LLC, it has entered into definitive agreement (the “Agreement”) to purchase a property in Broward County, Florida that will double as the new corporate headquarters and as a retail pharmacy. This third location will facilitate the Company’s growth by expanding the Company’s pharmacy operations in the South Florida region.

On October 25, 2018, Progressive Care executed the Agreement to purchase an 11,000 square foot property (the “Property”) in Hallandale Beach, Florida for $1,800,000 USD. The light distribution building has many of the necessary features including parking, zoning, structural integrity, and modern equipment necessary to accommodate the Company’s needs for continued growth. Upon closing (the “Closing”), the Company plans to procure architectural plans and apply for the necessary permits to begin restructuring the floor plan to be more conducive to an industrialized pharmacy workflow. The Closing is expected to occur pursuant to the satisfaction of customary closing conditions.

The Agreement calls for payments to be made at Closing to the sellers in the form of a convertible promissory note for $300,000 secured by the Property and $1.5 million in cash to be financed through a traditional commercial mortgage for the total purchase price of $1,800,000, which is in addition to mortgage origination fees, real estate commissions, and other costs associated with the purchase.

“This Agreement is a testament to the Company’s growth this year,” said S. Parikh Mars, Chief Executive Officer of Progressive Care Inc. “We are about to embark on a new chapter of our development. As owners of our own space, we cement our standing in the Hallandale Beach, Florida community while also planning and preparing for our future.”

Continue Reading

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks